Georgescu SP, Aronovitz MJ, Iovanna JL, Patten RD, Kyriakis JM, Goruppi S. Decreased metalloprotease 9 induction, cardiac fibrosis, and higher autophagy after pressure overload in mice lacking the transcriptional regulator p8. Am J Physiol Cell Physiol 301: C1046 -C1056, 2011. First published July 20, 2011 doi:10.1152 doi:10. /ajpcell.00211.2011cluding the deposition of excess extracellular matrix, is key to the pathogenesis of heart failure. The stress-inducible transcriptional regulator p8 is increased in failing human hearts and is required both for agonist-stimulated cardiomyocyte hypertrophy and for cardiac fibroblasts matrix metalloprotease-9 (MMP9) induction. In the heart, upregulation of autophagy is an adaptive response to stress and plays a causative role in cardiomyopathies. We have recently shown that p8 ablation in cardiac cells upregulates autophagy and that, in vivo, loss of p8 results in a decrease of cardiac function. Here we investigated the effects of p8 genetic deletion in mediating adverse myocardial remodeling. Unstressed p8Ϫ/Ϫ mouse hearts manifested complex alterations in the expression of fibrosis markers. In addition, these mice displayed elevated autophagy and apoptosis compared with p8ϩ/ϩ mice. Transverse aortic constriction (TAC) induced left ventricular p8 expression in p8ϩ/ϩ mice. Pressure overload caused left ventricular remodeling in both genotypes, however, p8Ϫ/Ϫ mice showed less cardiac fibrosis induction. Consistent with this, although MMP9 induction was attenuated in the p8Ϫ/Ϫ mice, induction of MMP2 and MMP3 were strikingly upregulated while TIMP2 was downregulated. Left ventricular autophagy increased after TAC and was significantly higher in the p8Ϫ/Ϫ mice. Thus p8-deletion results in reduced collagen fibrosis after TAC, but in turn, is associated with a detrimental higher increase in autophagy. These findings suggest a role for p8 in regulating in vivo key signaling pathways involved in the pathogenesis of heart failure. fibrosis; knockout; heart failure; nupr1; p8 protein REMODELING of the left ventricle (LV) is a consequence of multiple cardiovascular diseases including heart failure, hypertension, and myocardial infarction (20, 36, 45) . This process consists of myocyte apoptosis and the dynamic synthesis and breakdown of extracellular matrix network (ECM) proteins.
ies of mice with targeted mmp9 deletion have implicated this factor in LV dilation-associated remodeling (2, 8, 30, 49) . The inability to efficiently produce enzymes responsible for ECM breakdown has been generally linked to a milder phenotype and lower apoptosis in most cardiovascular disease models.
In addition to remodeling, apoptosis plays a major role in the development of heart failure (21, 35) , and the role of apoptotic signaling initiated by the endoplasmic reticulum (ER) in the heart has been determined (32, 37) . Accordingly, ablation of C/EBP homologous protein (CHOP) in mice attenuates apoptosis and dysfunction following pressure overload (10) .
Autophagy may also contribute to cardiac pathology (28, 29, 45) . Autophagy is a tightly regulated lysosomal process important for the turnover of the cellular organelles and cytosolic material and for the resulting production of metabolic intermediates and building blocks. Autophagy represents a basal housekeeping mechanism in the heart, maintaining adequate levels of metabolic intermediates (39, 45) . Autophagy requires two ubiquitin-like systems: one leading to the conjugation of Atg12 to Atg5, and the second converting (via lipidation) the microtubule-associated protein 1 light chain 3 form (LC3-I) to the autophagic vesicle (autophagosome)-associated form (LC3-II). Several proteins, such as the sequestosome 1 (SQSTM1), possess LC3-interacting domains and serve as adaptors for the autophagic process, targeting proteins to burgeoning autophagosomes (24, 33, 51) . Basal cardiac autophagy is altered following stress triggered by cardiovascular diseases, including ischemic injury, cardiac hypertrophy, and heart failure (27, 29, 45) . Thus autophagy appears to play a protective role in both rat neonatal and adult cardiomyocytes, while its untimely or excessive activation can cause cell death (15, 33, 39 ). Yet, its role in the heart is still poorly understood.
p8 (nupr1) is a nuclear basic helix-loop-helix protein that is strongly induced in response to stress. It has been implicated in several diverse context-dependent functions, including transcriptional regulation, cell cycle control, muscle differentiation, diabetic nephropathy, as well as apoptotic regulation (4, 11, 12, 26, 48) . Accordingly, p8 acts as a transcriptional coregulator and interacts with members of the transcriptional machinery, including AP1 complex, FoxO3, p53, and p300 among others (13, 19, 24, 25) .
Our work has shown that p8 is induced in failing human hearts, by a process reversed upon the therapeutic implantation of a LV assist device (14) . p8 is required for endothelinstimulated cardiomyocyte hypertrophy and for tumor necrosis factor (TNF) induction in cardiac fibroblasts of MMP9. Consistent with this, in primary fibroblasts and cancer cells, p8 associates with the MMP9 promoter and is necessary for MMP9 transcription.
We have recently unveiled a role for p8 in controlling autophagy (25) . Thus p8 RNA interference (RNAi) increases basal autophagy in cells and decreases cellular viability by regulating the levels of Bnip3 protein, a known pro-autophagic target. Notably, we have shown that p8-deficient mouse hearts have higher basal autophagy and bnip3 levels. These mice develop LV wall thinning and chamber dilation, with consequent impaired basal cardiac function.
Here we further investigated the in vivo role of p8 in cardiac remodeling induced by transverse aortic constriction (TAC). We found that unstressed p8-deficient mouse hearts have altered patterns of expression of genes associated with fibrosis. p8Ϫ/Ϫ hearts also manifest higher autophagy and apoptosis. We also show that p8 expression is strongly induced in the LV of p8ϩ/ϩ mice after TAC, and that disruption of p8, despite causing a reduction in MMP9 induction, triggers a striking compensatory upregulation of MMP2 and MMP3 as well as a down modulation of TIMP2, consistent with the observed reduction in fibrosis. By contrast, TAC-induced autophagy is significantly higher in the LV of p8-deficient mice. Our results suggest an unexpectedly complex role for p8 in heart failure, promoting both pathological (increased fibrosis) and protective (autophagy and apoptosis inhibition) processes.
MATERIALS AND METHODS
qPCR and RT-PCR. Total RNA was isolated and PCRs were performed as described in Ref. 12 . Quantitative real-time PCR (qPCR) of mouse RNA was performed using Quantitect SYBR Green Kit (Qiagen) according to the manufacturer's instructions. qPCR was performed using an Eppendorf 96-well thermoamplifier. The amount of each product was determined from the relative standard curves constructed with serial dilutions of the control cDNA. End-point RT-PCR was performed as by Gorruppi et al. (14) , and ␤-actin or gapdh were co-amplified as controls. The sequences of the oligonucleotide primers used will be provided upon request.
Immunohistological analysis. Hematoxylin and eosin or Masson's trichrome staining of the LV fixed in 4% paraformaldehyde were performed as described by Donaldson et al. (7) . Randomly chosen frames from Masson's trichrome-stained sections were quantified to assess the degree of myocardial fibrosis using ImageJ software.
Apoptotic cell assay. The terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL assay) was performed as described by Patten et al. (43) . The number of TUNEL-positive cardiomyocytes, identified by ␣-sarcomeric actin staining, was expressed as percentage of total cells.
Soluble collagen analysis. Sircol soluble collagen assay was performed as indicated by the manufacturer (Biocolor). Briefly, fresh heart samples were weighted and digested overnight at 4°C in 0.5 M acetic acid containing 0.1 mg/ml pepsin (Sigma-Aldrich). One milliliter of Sircol Dye reagent (Sirius red) was added to each sample (100 l) and incubated for 30 min at room temperature on a rotating platform. Sircoll dye binding does not discriminate between collagen types and is reduced if collagens are denaturated. The Eppendorf tubes containing the collagen-dye insoluble complex were centrifuged for 10 min at 12,000 rpm and washed once with 750 l of cold acid/salt wash reagent, and the pellets were dried after carefully removing all the liquid. Each pellet was then solubilized with 250 l of alkali reagent and the absorbance read at 550 nm. Serial dilutions of a known concentration of rat collagen (provided by the manufacturer) in water were processed in parallel and used to create the standard curve.
Protein isolation and Western blotting. The Western blots were performed as described by Kong et al. (25) . Total proteins were extracted in ice-cold RIPA buffer containing protease inhibitors and quantified using Bradford solution (Bio-Rad). Expression levels were normalized to loading controls by using ImageJ software (http:// rsb.info.nih.gov/ij/). For Western blots, primary antibodies used include anti-LC3B, ATG12-5, poly (ADP-ribose) polymerase (PARP), P-eIF2␣ and were from Cell Signaling Technologies, and antibodies against MMP9, MMP13, atrial natriuretic factor (ANF), CHOP, GRP78, Bax, Sqstm1, Bnip3, tubulin, and actin were from Santa Cruz Biotechnologies. Appropriate peroxydase-conjugated secondary antibodies were from Santa Cruz Biotechnologies or Jackson, whereas ECL reagents were from Boston Bioproducts.
Animal experiments. p8Ϫ/Ϫ mice and wild-type (p8ϩ/ϩ) littermate controls in C57BL/6J background have been previously described (11) . Ten-to twelve-week-old, age-matched, p8Ϫ/Ϫ (n ϭ 10) and p8ϩ/ϩ mice (n ϭ 10) underwent TAC or sham operation (n ϭ 5 each), and 4 wk later hearts were harvested while mice were under deep anesthesia for analysis. Both male and female were used in the study. For echocardiography mice were imaged in the left lateral decubitus position using a Phillips-Sonos 7500 echocardiography system equipped with 11 MHz sector array and 10 -15 MHz linear array transducers. Digital echocardiographic images were analyzed with Phillips-based analysis software (qLAB) on XP-based platform coupled with the echocardiography system. LV end-diastolic diameter (LVEDD) and end-systolic diameter (LVESD) were measured, and fractional shortening (FS) was calculated as (LVEDD Ϫ LVESD/ LVEDD) ϫ 100%. Studies and analysis were done by investigators blinded to the mice genotype. All procedures were performed according to the animal protocols approved by Tufts University Animal Care and Use Committee.
Statistical analysis. Independent experiments were pooled when the coefficient of variance could be assumed to be equal. Statistical significance was evaluated with Prism 5.0 software by using nonpaired, two-tailed Student's t-test (n ϭ number of experiments or animals analyzed). P values below 0.05 were considered significant and if lower as indicated.
RESULTS
To determine the role of p8 in cardiac remodeling, we analyzed the effects of p8 genetic deletion in a pressureoverload model of heart failure. To this end, age-matched p8Ϫ/Ϫ and wild-type (p8ϩ/ϩ) mice underwent TAC or sham operation, and their hearts were analyzed 4 wk later.
Altered expression of fibrosis markers in p8Ϫ/Ϫ mice. p8 is a stress-inducible transcriptional regulator, and its genetic deletion is associated with LV dilation, wall thinning, and impaired baseline cardiac function (25) . First, to determine the physiological relevance of p8, we analyzed the regulation of its gene expression in the LV of sham-and TAC-operated mice. A low level of basal p8 mRNA was present in the LV of unstressed p8ϩ/ϩ mice and was significantly increased after TAC, as quantified by end-point RT-PCR (3.2 Ϯ 0.7-fold) or qPCR (4.2 Ϯ 1.3-fold) (Fig. 1, A and B, respectively). We then analyzed in LV samples the expression of genes linked to cardiac hypertrophy and fibrosis. Interestingly, unstressed p8Ϫ/Ϫ mice exhibited increased basal expression of col1a2 and col3a1 (Fig. 1C) . After TAC, p8Ϫ/Ϫ mice displayed a lower induction of col1a2 and col3a1 and a modest upregulation of tnf␣ (Fig. 1C ) compared with p8ϩ/ϩ mice. In p8ϩ/ϩ or p8Ϫ/Ϫ LV samples, no significant differences in the expression of the hypertrophic marker anf or of the cytokines ctgf and vegf were observed either at baseline or after TAC (Fig.  1C) . We also analyzed the expression of TGF␤ and of the plasminogen activator inhibitor-1 (PAI-1), a TGF-␤ signaling target, and found a similar regulation in p8ϩ/ϩ and p8Ϫ/Ϫ LV samples (not shown). Thus, compared with p8ϩ/ϩ controls, p8-deficient mice have higher levels of fibrotic gene transcripts in unstressed LV and have an attenuated induction of the same markers after TAC.
Attenuated fibrosis in p8Ϫ/Ϫ mice after TAC. We further analyzed the consequences of dysregulation of ECM molecules after TAC in the heart. At gross examination, the hearts of p8ϩ/ϩ and p8Ϫ/Ϫ mice were comparable in size at baseline (see Fig. 6C and not shown). Morphometric analysis of hematoxylin/eosin and of Masson's trichrome-stained histological sections showed no macroscopic differences ( Fig. 2A ), but higher collagen content was detected in sham-operated p8Ϫ/Ϫ mice compared with sham p8ϩ/ϩ animals ( Fig. 2B ). The cardiac remodeling following pressure overload was accompanied by extensive fibrosis of the ventricular wall in p8ϩ/ϩ mice, but we observed a significantly lower degree of interstitial fibrosis induction in LV of p8Ϫ/Ϫ mice (Fig. 2, A and B) . To confirm these findings we analyzed the newly synthesized soluble LV collagen by using the Sircoll colorimetric assay. This method allows quantification of the new collagen generated but not yet cross-linked. We found that, compared with p8ϩ/ϩ mice, LV of p8Ϫ/Ϫ animals had less Sircoll-detectable soluble collagen content after TAC (Fig. 2C) .
p8Ϫ/Ϫ mice show reduced MMP9 but elevated MMP2 and MMP3 induction after TAC. The changes in cardiac collagen deposition described above suggested to us that p8 might regulate mechanisms involved in collagen degradation. Altered expression of metalloproteases has been demonstrated in a number of pathophysiological conditions, including remodeling occurring in myocardial infarction and heart failure (49) . Our data suggested that p8 might act in vivo to prevent collagen loss. However, our previous studies have shown that p8 is required for mmp9 induction by cardiac fibroblasts. Thus we investigated first whether p8 deletion similarly interferes with mmp9 upregulation in vivo following TAC. MMP9 levels were similarly low in LV of sham-operated p8Ϫ/Ϫ and p8ϩ/ϩ mice. Compared with p8ϩ/ϩ controls, p8Ϫ/Ϫ mice exhibited significantly less MMP9 protein induction in their LV after TAC (Fig. 2D) .
We then analyzed by qPCR mmp9 expression in the LV of sham-and TAC-operated p8ϩ/ϩ and p8Ϫ/Ϫ mice. In agreement with the Western blot results and with our previous findings in primary rat cardiac fibroblasts (14) , mice lacking p8 had a significantly lower induction of mmp9 following TAC compared with p8ϩ/ϩ mice (Fig. 2E) . These results suggested a conundrum: p8 appears necessary for cardiac collagen deposition, yet is also important for the expression of a collagendegrading enzyme-MMP9. Might p8 affect the expression of other MMPs or MMP regulatory mechanisms that affect collagen breakdown?
MMPs have both overlapping substrate specificities and peculiar functions, which are finely tuned through the expression of tissue inhibitors of metalloproteinases (TIMPs). Accordingly, the loss of mmp9 activities has been shown be partially compensated for by the upregulation of MMP2, MMP13, and complemented by upregulation of TIMP1 (8, 50) . Hence, we investigated whether p8 deletion might modify the LV expression of mmp2, mmp3, mmp13, timp1, and timp2 following TAC. Their expression levels were normalized to actin and compared with mmp9 (Fig. 3) . The levels of mmp2, mmp3, mmp13, timp1, and timp2 were similar in LV of shamoperated p8Ϫ/Ϫ and p8ϩ/ϩ mice. Compared with p8ϩ/ϩ controls, p8Ϫ/Ϫ mice had a significantly higher mmp2 and mmp3 expression along with a lower timp2 induction after TAC. As was shown in Fig. 2 , B and C, upregulation of mmp9 was lower in the p8Ϫ/Ϫ mice. Both mmp13 and timp1 levels were similarly upregulated in the p8Ϫ/Ϫ and p8ϩ/ϩ mice after TAC. These data suggest that in p8Ϫ/Ϫ mice, the lack of MMP-9 upregulation after TAC is associated with a compensatory change in the expression of other mmps and specific timps. This overall increase in enzymes that degrade collagen may explain in part the decrease in collagen levels in p8Ϫ/Ϫ mice consequent to TAC.
Fetal gene activation is a hallmark of hypertrophic remodeling, and we used ANF as an internal control for the TAC experiment. In p8ϩ/ϩ and p8Ϫ/Ϫ sham-operated mice, ANF was barely detectable and was upregulated after TAC to a similar extent in both genotypes, consistently with our gene expression data in Fig. 1C .
Increased baseline apoptosis in p8-deficient mice. Cardiomyocyte apoptosis is a key triggering event in the remodeling process that contributes to heart failure. Cardiomyocyte death is accompanied by fibrosis to replace lost cardiomyocytes. We have previously shown that p8 silencing in cells triggers apoptosis (25) . Here we investigated the apoptosis levels in vivo in sham-unstressed mice and following TAC LV of p8Ϫ/Ϫ and p8ϩ/ϩ mice. Our findings suggest that p8Ϫ/Ϫ mice have elevated baseline apoptosis; however, TAC triggers an increase in apoptosis to near equal levels for p8ϩ/ϩ vs p8Ϫ/Ϫ mice.
Thus, at baseline, p8-deficient mice expressed higher levels of Bax protein and higher levels of cleaved nuclear PARP (Fig. 4A) . In agreement with previous reports (10, 22, 40) , these apoptosis markers were upregulated after TAC, and we found a similar increase in both p8Ϫ/Ϫ and p8ϩ/ϩ mice. Accordingly, the number of TUNEL-positive cardiomyocytes, identified by ␣-sarcomeric actin staining, was significantly higher at baseline in the p8Ϫ/Ϫ mice compared with p8ϩ/ϩ animals and was increased by pressure overload to a similar extent in both genotypes (Fig. 4B) .
A large body of evidence supports a role for apoptotic signaling initiated by the ER in the development of heart failure (37). In cancer cells, p8 has been shown to mediate cannabinoid-activated ER-stress signaling and apoptosis (4, 47) . We thus investigated ER-stress signaling markers in the hearts of p8Ϫ/Ϫ and p8ϩ/ϩ mice subjected to pressure overload. As previously reported (10, 42), we found that eIF2␣ phosphorylation (a mechanism downregulating protein synthesis under stress), as well as the levels of CHOP TF and of the ER chaperone GRP78, were all increased in the hearts after TAC. Activation of the XBP-1-dependent pathway, a branch of the unfolded protein response, was also assessed by determining its splicing by RT-PCR (not shown). None of these ER stress markers showed significant differences between p8ϩ/ϩ and p8-deficient mice compared with sham-or TACoperated mice (Fig. 4C) . Thus the higher level of baseline apoptosis in p8-deficient mouse hearts is not associated with increased ER-stress activation. Both p8Ϫ/Ϫ and p8ϩ/ϩ mice develop similar levels of apoptosis and ER-stress signaling upregulation following TAC.
p8-deficient mice have higher baseline autophagy, which is enhanced after TAC. Autophagy in the heart is a homeostatic mechanism for the maintenance of normal cardiac function and morphology. Several pathophysiological conditions, including heart failure, have been associated with an increase in autophagy (6, 15, 29, 45) . We have previously shown that either p8 silencing or deletion causes an increase in proautophagic gene expression and autophagic markers, coinciding in vivo with decreased baseline cardiac functionality (25) . We thus investigated the effects of p8 deletion on autophagy levels in sham-operated mice and after TAC by analyzing the protein levels of LC3-II, ATG12-5, and SQSTM1 in Western blots. Consistent with our previous findings, disruption of p8 led to Equal amounts of total proteins were analyzed with antibodies against BAX, cleaved PARP (clvd PARP), and actin (ACT). The bands were quantified by densitometry and normalized to actin levels (BAX and PARP, *P Ͻ 0.05, n ϭ 4 each). B: quantification of apoptosis after terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) staining of the hearts of p8ϩ/ϩ and p8-deficient mice (n ϭ 4 each). TUNEL-positive cardiomyocytes, identified by ␣-sarcomeric actin staining, were quantified by examination of 8 random fields per heart. Values are means Ϯ SE (*P Ͻ 0.05). C: endothelial reticulum (ER) stress signaling at baseline and in failing hearts from p8Ϫ/Ϫ and p8ϩ/ϩ mice. Western blot analysis was carried out using anti-P-eIF2␣, CHOP, GRP78, and ACT antibodies. Representative membranes are shown; no significant differences between p8Ϫ/Ϫ and p8ϩ/ϩ mice after TAC were found (n ϭ 6 for each genotype, P Ͼ 0.05).
significantly elevated levels of LC3-II and ATG12-5 in shamoperated p8Ϫ/Ϫ animals compared with p8ϩ/ϩ mice, confirming a greater basal autophagy (Fig. 5A) . Autophagy is increased in the pressure-overload model, and accordingly we detected upregulation of LC3-II and ATG12-5 levels after TAC in both p8-deficient and p8ϩ/ϩ mice. LC3-II levels were significantly higher in p8Ϫ/Ϫ mice indicating a higher level of TAC-induced autophagy (Fig. 5A) (27) . Consistent with this, SQSMT1 protein levels were significantly lower in the hearts of p8-deficient mice compared with p8ϩ/ϩ controls, indicative of an increase in autophagy levels (39) . We have previously reported that both mRNA and protein expression of proautophagic protein Bnip3 are higher in p8Ϫ/Ϫ mice. Bnip3 mediates autophagy induced by p8 silencing in both cultured neonatal cardiomyocytes and cancer cells (25) . We thus analyzed bnip3 mRNA levels in the hearts of sham-operated mice and after TAC by PCR. Consistent with Kong et al. (25), we found significantly higher bnip3 levels in shamoperated p8-deficent animals compared with p8ϩ/ϩ mice. Four weeks after TAC, both p8Ϫ/Ϫ and p8ϩ/ϩ animals had increased bnip3 expression, with the p8-deficient mice showing higher bnip3 levels than the p8ϩ/ϩ controls (Fig.  5, B and C) .
These results demonstrate that not only does p8 suppress baseline cardiac autophagy, but p8 also likely might function to decrease TAC-stimulated autophagy in the heart. p8 loss is associated with cardiac dysfunction: effects after TAC. We have previously shown that p8 is induced in failing hearts of humans, as well as by stimuli associated with cardiac remodeling (14) . Moreover, our previous data indicated that p8 genetic deletion is associated with a decrease in baseline cardiac function (25) . We thus analyzed the possible functional consequences of p8 loss in vivo during heart failure induced by pressure overload. We performed echocardiographic recordings of p8ϩ/ϩ and p8Ϫ/Ϫ mice and measured their LV wall dimensions and ventricle performance at baseline before operation and after 4 wk, the day before the animal was euthanized.
Echocardiographic analysis indicated that at baseline p8Ϫ/Ϫ mice manifest a modest, but significant, LV dilation, wall thinning, and lower fractional shortening compared with p8ϩ/ϩ mice, a result consistent with Kong et al. (25) . Four weeks after TAC, p8ϩ/ϩ and p8Ϫ/Ϫ mice developed similar LV dilation and decreased LV function, as measured by endsystolic and end-diastolic dimensions and increased heart wall thickness. The decrease in fractional shortening after TAC was similar in p8-deficient and p8ϩ/ϩ mice (Fig. 6, A and B, and Table 1 ). No significant differences were noted among p8ϩ/ϩ and p8Ϫ/Ϫ mice with respect to mortality or cardiac enlargement after TAC, as assessed by heart weight-to-body ratio (n ϭ 15 for each genotype). No significant differences were noted in total body, lung, and kidney weights (Fig. 6C) . Neither hematoxilin/eosin nor trichrome staining of histochemical sections of liver and kidney revealed significant morphological differences or fibrotic lesions at baseline or following TAC between sham-operated and TAC p8Ϫ/Ϫ and p8ϩ/ϩ mice (not shown).
These results suggest either that 1) p8 function in the heart might be compensated by other signaling mechanisms in the process of hypertrophy and failure induced by pressure overload, 2) the TAC procedure produces a sufficiently large degree of cardiac stress as to squelch any differences between p8ϩ/ϩ vs. Ϫ/Ϫ mice, or, most likely, 3) p8 performs multiple and complex functions in the heart, some Fig. 6 . p8 genetic deletion is associated with cardiac dysfunction; effects after TAC. Echocardiographic data for agematched p8Ϫ/Ϫ and p8ϩ/ϩ mice were collected before the sham or TAC operation. As we reported previously (25) , p8Ϫ/Ϫ mice have LV dilation (P Ͻ 0.05), LV posterior wall thinning (P Ͻ 0.05), and lower fractional shortening (P Ͻ 0.01) (n ϭ 16 for p8ϩ/ϩ; n ϭ 17 for p8Ϫ/Ϫ). A: echocardiographic data for p8Ϫ/Ϫ and p8ϩ/ϩ mice recorded 4 wk after sham or TAC operation (n ϭ 6 fors and n ϭ 10 for TAC, for each genotype). LVEDD and LVESD, LV end-diastolic and end-systolic dimension, respectively (in mm). AWT and PW: anterior and posterior wall thickness (in mm). B: fractional shortening (FS) calculated from A as (LVEDD Ϫ LVESD/LVEDD) ϫ 100%. Numeric values (means Ϯ SE) for echocardiographic data are shown in Table 1 . C: ratios of heart weight to body weight (RVϩLV), LV, right ventricle (RV), lung (Lung), liver (Liver) weight to body weight, and total body weight in sham-or TAC-operated mice, in p8Ϫ/Ϫ and p8ϩ/ϩ mice. Values are means Ϯ SE. LVEDD and LVESE, LV end-diastolic and end-systolic, respectively; AWT, anterior wall thickness; PWT, posterior wall thickness; FS, fractional shortening; TAC, transverse aortic constriction. *P Ͻ 0.05 for both LVEDD and LVESD; †P Ͻ 0.01 for FS. Baseline animals; n ϭ 16 for p8ϩ/ϩ; n ϭ 17 for p8Ϫ/Ϫ. Operated animals; n ϭ 6 for sham and n ϭ 10 for TAC, for each genotype.
of which essentially compensate for or cancel out the effects of others.
DISCUSSION
Cellular stress response pathways are controlled by a number of signaling molecules and transcriptional regulators, which by sensing and transmitting the information allow an adaptive response (28, 29) . The basic helix-loop-helix protein p8 is a transcriptional regulator involved in multiple stressactivated cellular responses (12) . Our previous work, using cultured cells, has suggested a function for p8 in key signaling events associated with heart failure (5, 12). The present study investigates p8 role in vivo in LV remodeling induced by pressure overload. Our results suggest a surprisingly complex, an often contradictory function for p8 in cardiac physiology and pathology that could not have been predicted from the cell culture models we used previously.
p8 deletion alters fibrotic gene expression. The cardiac adaptive response to pathophysiological conditions is associated with changes in gene expression and reemployment of the developmental program. p8 mRNA levels are increased in p8ϩ/ϩ failing hearts consequent to TAC, which is consistent with our previous studies of p8 regulation in primary rat cardiomyocytes by GPCR agonists and with its induction in failing hearts of humans (14) .
Increased cardiac fibrosis compromises the contractile properties of the heart and is a hallmark of pathological cardiac hypertrophy and heart failure (34, 41, 49) . Unstressed p8 knockout mice hearts have higher collagen gene expression and fibrotic areas, both of which likely contribute to the reported loss of function (25) . Still, the effects we found of p8 disruption on collagen deposition and mmp expression are complex. Upon TAC, p8 absence impairs collagen deposition, raising the possibility that p8 might negatively regulate collagen degradation. Contrary to this, p8 disruption reduces MMP9 levels, which is consistent with our earlier findings from cultured cardiac fibroblasts. However, p8 disruption also increases TAC-induced mmp2, mmp3, and timp2 levels, suggesting that p8 indeed negatively regulates mmp expression and providing a potential explanation for the decreased levels of collagen in p8Ϫ/Ϫ hearts after TAC. In support of this idea, because of their multiplicity and substantial substrate overlap, MMPs and TIMPs are thought to have redundant functions (46) . Nevertheless, the role of p8 in inducing mmp9 expression may still be important to the pathogenesis of cardiac remodeling. The structural changes in myocardial ECM during LV remodeling requires proteolysis (49) . The lower induction of mmp9 may explain why ECM degradation and, on the other hand, collagen deposition are attenuated after TAC in the absence of p8. Indeed, our results are also consistent with previous studies demonstrating a prominent role of MMP-9 in myocardial ECM remodeling in cardiac rupture, infarction, and LV remodeling after pressure overload (8, 18, 38) . The enhanced expression of mmp2, mmp3, and the lower timp2 levels in the p8Ϫ/Ϫ mice after TAC are likely responsible for the apparent conundrum observed here, where p8 mice have a decreased mmp9 induction but less fibrosis after TAC (Fig. 7) . The exact mechanism for this compensatory effect is unknown; it might be a direct promoter regulation by p8 or, more likely, an MMP9 substrate might regulate other mmps. In fact, in vivo compensatory upregulation of MMPs has been reported for mmp7 knockout mice and for mmp9 knockout mice both in an infarction and in a vein graft animal models (8, 50) . Therefore, considering the lower mmp9 induction and the compensatory enhanced expression of other MMPs that leads to lower fibrosis after TAC, we might consider p8 absence as beneficial, at least with regard to ECM regulation.
p8-deficient mice have increased autophagy and apoptosis at baseline. Activation of autophagy plays a causative role in cardiac pathologies. Autophagic cell death as cause of cellular degeneration has been demonstrated in patients with hypertrophied and failing myocardium after ischemia or in dilated cardiomyopathy (6) . Incomplete autophagy in lysosome-associated protein 2-deficient mice (Lamp2) causes autophagosome accumulation and cardiomyopathy, whereas atg5 deletion in adult mice leads to hypertrophy and contractile disfunction (6, 39) . Our previous work has shown that unstressed p8-deficient hearts have higher levels of autophagy, which is associated with pro-autophagic bnip3 gene upregulation (25) . In the current study we observed higher Bax protein in unstressed p8Ϫ/Ϫ hearts. Furthermore, PARP was cleaved, indicating caspase 3 activation, and the number of TUNEL-positive cardiomyocytes was higher in p8Ϫ/Ϫ mouse hearts compared with p8ϩ/ϩ controls. All these results support a higher basal apoptosis in p8-deficient mice. Accordingly, we have shown that in vitro, p8 RNAi induces atg5-dependent autophagy and bnip3-dependent apoptosis (25) . In vivo, the increase of basal apoptosis might be in part responsible for the wall thinning and the decreased heart function we have reported and ultimately for the increased fibrosis at baseline. Alternatively, the increase in baseline LVEDD may be due to cardiomyocyte slippage due to the loss of interstitial collagen.
Autophagy represents a maladaptive response to hemodynamic stress (45, 54) . TAC-induced upregulation might help eliminate misfolded proteins and damaged mitochondria, thus protecting from reactive oxygen species and apoptosis. However, the point at which autophagic activity becomes autophagic cell death has not yet been defined (29, 33, 45 ). In Fig. 7 . Scheme of p8 role in TAC-induced heart remodeling. A complex role for cardiac p8 in regulating fibrosis, autophagy, and apoptosis processes. p8 expression is strongly induced in LV of p8ϩ/ϩ mice after TAC, and disruption of p8 causes a reduction in MMP9 induction but triggers a compensatory upregulation of MMP2/3 leading to a reduction in fibrosis. By contrast, TAC-induced autophagy is significantly higher in p8-deficient mice.
p8Ϫ/Ϫ mice pressure overload-induced autophagy levels were superimposed on the basal levels. Accordingly, increases of LC3-II and Atg5-12 conjugation indicated autophagy activation after TAC and were higher in p8-deficient mice. The adapter sequestosome (SQSTM1) targets proteins for autophagosomal degradation and accumulates in cardiomyocytes when autophagy is suppressed (39) . After TAC, p8-deficient mice had lower SQSTM1 levels, suggesting a higher autophagic turnover. Interestingly, we also found an increase in LC3-I levels after the TAC in both p8-deficient and p8ϩ/ϩ mice. This might reflect either the increased activity of pro-autophagic transcription factors as FoxO3 or a protein accumulation due to a general delay in the autophagic flux after TAC (23, 53) .
In the heart, accumulation of misfolded proteins after pressure overload induces ER stress (42) , and p8 was shown to mediate ER stress-induced apoptosis by cannabinoid in cancer (4, 47) . When comparing p8-deficient and p8ϩ/ϩ mice, we found a similar activation of ER-stress markers in either unstressed hearts or after TAC. This suggests that, at least in the heart, p8 absence does not activate nor significantly blocks this cell-damaging signaling.
What is the role for p8 in the failing hearts? p8 deficiency causes upregulation of autophagy, but the role of this process in the heart is still controversial. In an ischemia-reperfusion (I/R) model, upregulation of autophagy can protect from cell death because either pharmacological inhibition or interference of atg5 functions will worsen the consequences. Conversely, the inability to upregulate autophagy during sustained pressure overload causes LV dilation in mice lacking atg5 in their heart (39), while pressure overload enhances cardiac autophagy and remodeling in Beclin-overexpressing mice (9) . Interestingly, much of the I/R damage seems mediated by Bnip3 upregulation, as its overexpression causes myocytes autophagy and cell death, while its silencing rescues both (16, 17) .
The reduction in collagen accumulation and mmp induction have been proven to be beneficial (18) ; however, despite a significant decrease in mmp9 induction and a lower fibrosis, p8Ϫ/Ϫ mice develop a similar loss in heart function after TAC compared with p8ϩ/ϩ mice. A possible explanation might be that beneficial aspects deriving from a milder fibrotic induction are compensated by the enhanced cardiac autophagy. In fact, in vitro p8 deficiency causes autophagy-induced apoptosis (25) . In our study, sham-operated p8Ϫ/Ϫ mice have indeed higher autophagy and myocyte apoptosis compared with p8ϩ/ϩ mice. This difference in autophagy is maintained between the genotypes after TAC, and we similarly found a trend toward a higher apoptosis in the p8Ϫ/Ϫ mice, although this trend did not reach statistical significance. This increased myocyte apoptosis might thus be responsible for the lack of difference in heart function seen after TAC.
Mice heterozygous for Gata4 have a similar mild decrease in heart function and LV dilation at baseline (1). However, in contrast to p8Ϫ/Ϫ mice, after pressure overload these animals develop decompensated heart failure and higher myocardial fibrosis, which are added to the preexisting basal phenotype. Thus p8 absence, while clearly not blocking the heart remodeling, does not result in a worsening of the heart function after TAC. To note, the effects of p8 deletion might also depend on the duration of the pressure overload experiment, or the basal cardiac pathology in the p8Ϫ/Ϫ might mask the differences after TAC. On the other hand, p8 expression might be regulated over the time in the failing heart and the consequences of p8 loss difficult to determine in a total body knockout animal. On this line, p8 protein levels are downregulated in the failing human hearts after therapeutic implant of a LV assisted device (14) . All these considerations are in line with the multifaceted and controversial characteristics reported for this molecule so far (3, 12) . Our findings support an in vivo role for p8 in ECM remodeling during the onset of heart failure, provide insights on the involvement of autophagy in the heart, and further our understanding of the molecular aspects of cardiovascular diseases.
